Skip to main content
4/17/2017

Register Now for the CDF Research Symposium

Are you living with celiac disease or caring for someone with celiac disease? Do you want to partner with researchers to share your experiences living with celiac disease? Then make your voice heard! Join CDF’s Patients As Partners Research Symposium on June 3, 2017, to become a Celiac Disease Patient Advocate and learn how to engage…

Continue Reading
4/7/2017

Study Finds Potential Link Between Reovirus and Celiac Disease

A research study published in the journal, Science, may have established a link between reovirus and celiac disease. Although reovirus is considered a common and often harmless virus, the study, co-authored by CDF Medical Advisory Board member, Stefano Guandalini, MD, and CDF Research Committee member, Sonia Kupfer, MD, determined that the reovirus, T1L, in some cases,…

Continue Reading
4/7/2017

FDA Allows Marketing of First Direct-to-Consumer Tests That Provide Genetic Risk Information for Certain Conditions, Including Celiac Disease

Celiac Disease Foundation welcomes the FDA announcement that 23andMe can offer accessible, lower-cost, direct-to-consumer genetic screening for a number of diseases, including celiac disease. Celiac disease is a serious, genetic, autoimmune disorder caused by an immune reaction to the ingestion of gluten. Although it is often thought of as a rare disease, researchers tell us…

Continue Reading
3/24/2017

Gluten-Free Marketplace 2.0 Released

Celiac Disease Foundation is pleased to announce the release of Gluten-Free Marketplace 2.0, our completely updated, one-stop destination to search for all of your favorite gluten-free products, services, companies, and recipes. The Gluten-Free Marketplace is available at celiac.org/marketplace and as an app for iPhone and Android. Marketplace 2.0 showcases products and services from companies that…

Continue Reading
3/24/2017

Are You Too Fatigued to Have Sex? In Too Much Pain?

A year has passed since Celiac Disease Foundation launched its patient registry, iCureCeliac®. Since our launch, 2,300 participants have contributed their medical information and experiences living with celiac disease and non-celiac wheat/gluten sensitivity. This information will help researchers to better understand, develop treatments for, and ultimately cure celiac disease. Based on our recent data analysis…

Continue Reading
3/24/2017

Partnership with ImmusanT to Promote Phase 2 Clinical Trial of Nexvax2®, A Promising Celiac Disease Treatment

ImmusanT, a Cambridge, MA-based biotechnology company, has announced that Nexvax2®, an immunotherapy drug designed to protect celiac disease patients from gluten exposure, has successfully completed a Phase 1b clinical trial and is advancing to a Phase 2 trial. Currently, strict, lifetime adherence to a gluten-free diet is the only disease management protocol for celiac disease…

Continue Reading
3/24/2017

Celiac Disease Internal Medicine Residency Training Program at USC Keck School of Medicine Launched

Celiac Disease Foundation, in partnership with the University of Southern California (USC) Keck School of Medicine, and Board member Dr. Michael S. Karp, Chief of the Division of Geriatric, Hospital, Palliative and General Internal Medicine, is proud to launch a pioneering celiac disease training program for Internal Medicine residents. This program is made possible by…

Continue Reading